Yu et al. (78) examined the effect of glycyrrhizin (GL), and HMGB1 inhibitor, in NEC and reported that it might inhibit TLR4 and the downstream NF-κB/NLRP3 signaling pathway, resulting in decreased intestinal inflammation. This evidence concerns the gene HMGB1 and necrotizing enterocolitis.